MedPath
NMPA Approval

Ambrisentan Tablets

国药准字HJ20160364

May 8, 2021

H20160364

Drug Information

安立生坦片

凡瑞克

片剂

10mg

化学药品

May 8, 2021

May 7, 2026

Company Information

Applicant Company

100 Milverton Drive, Suite 800, Mississauga, ON, Canada, L5R 4H1

Manufacturing Company

Patheon Inc

2100 Syntex Court Mississauga, Ontario Canada L5N 7K9

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

安立生坦片 - NMPA 批准文号 | MedPath